The tumor growth (0 mm3 and 0 g of tumor) was effectively suppressed in all micewhen treated with BT-474 using anti-HER2 VHH-FcK and Trastuzumab (Figure 5b, left graph). The gene discussed is ERBB2; the disease is neoplasm.